| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/AJPGI.00174.2014 |
| P698 | PubMed publication ID | 25301186 |
| P50 | author | Simona E. Carbone | Q57003047 |
| Samy Sakkal | Q57003056 | ||
| Claude C A Bernard | Q73910810 | ||
| Anthony Park | Q81923912 | ||
| Ainsley M Robinson | Q85680336 | ||
| Joel C. Bornstein | Q46920767 | ||
| Kulmira Nurgali | Q50149515 | ||
| P2093 | author name string | Sarah Miller | |
| Richard Boyd | |||
| Valentina Jovanovska | |||
| Natalie Payne | |||
| P2860 | cites work | Clinical applications of mesenchymal stem cells | Q21198864 |
| Mesenchymal stem cells avoid allogeneic rejection | Q21245658 | ||
| Inflammatory bowel disease: clinical aspects and established and evolving therapies | Q21957029 | ||
| The immunomodulatory and neuroprotective effects of mesenchymal stem cells (MSCs) in experimental autoimmune encephalomyelitis (EAE): a model of multiple sclerosis (MS) | Q26823691 | ||
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| Human mesenchymal stem cells modulate allogeneic immune cell responses | Q28288692 | ||
| Mesenchymal stem cells in health and disease | Q29614296 | ||
| Multimodal in vivo imaging reveals limited allograft survival, intrapulmonary cell trapping and minimal evidence for ischemia-directed BMSC homing. | Q30530998 | ||
| Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy | Q33490119 | ||
| MSC frequency correlates with blood vessel density in equine adipose tissue | Q33605570 | ||
| Stem cell paracrine actions and tissue regeneration | Q33708216 | ||
| Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms | Q33713663 | ||
| Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress | Q33715744 | ||
| The smooth muscle cell in culture | Q33951416 | ||
| Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis | Q34202877 | ||
| Current and emerging drugs for the treatment of inflammatory bowel disease | Q34883210 | ||
| Treatment of inflammatory diseases with mesenchymal stem cells | Q34987147 | ||
| Neuron-like differentiation of bone marrow-derived mesenchymal stem cells | Q35003377 | ||
| Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects | Q35168236 | ||
| Mesenchymal stem cells: clinical applications and biological characterization. | Q35686355 | ||
| The effect of mesenchymal stem cell shape on the maintenance of multipotency. | Q50483087 | ||
| Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats. | Q50616625 | ||
| Flk-1+ adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice. | Q50866492 | ||
| Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation. | Q51053512 | ||
| Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. | Q53358865 | ||
| Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis. | Q53480954 | ||
| Enteric ganglioneuritis and abnormal interstitial cells of Cajal: features of inflammatory bowel disease. | Q53576667 | ||
| Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases | Q57005177 | ||
| Predictive value and clinical significance of myenteric plexitis in Crohn's disease | Q57128590 | ||
| The Value of Myenteric Plexitis to Predict Early Postoperative Crohn’s Disease Recurrence | Q57265437 | ||
| Comparative Analysis of Mesenchymal Stromal Cells Biological Properties | Q58998281 | ||
| Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease | Q35804026 | ||
| Diabetes-related alterations in the enteric nervous system and its microenvironment | Q35988135 | ||
| How mesenchymal stem cells interact with tissue immune responses | Q36141205 | ||
| Type 1 and 2 T helper cell-mediated colitis | Q36629338 | ||
| Inflammatory bowel disease: past, present, and future | Q36745440 | ||
| The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders | Q37104217 | ||
| Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells | Q37134013 | ||
| Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS | Q37183861 | ||
| Inflammatory bowel disease: Moving toward a stem cell-based therapy | Q37242568 | ||
| Intra-subject variability in human bone marrow stromal cell (BMSC) replicative senescence: molecular changes associated with BMSC senescence | Q37281919 | ||
| Mesenchymal stem cell homing: the devil is in the details | Q37407769 | ||
| Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes | Q37492370 | ||
| Adverse effects of biologics used for treating IBD. | Q37708646 | ||
| Review article: stem cell therapies for inflammatory bowel disease - efficacy and safety | Q37784039 | ||
| The enteric nervous system and neurogastroenterology. | Q37990818 | ||
| Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo | Q40662801 | ||
| Stem cell therapeutics: potential in the treatment of inflammatory bowel disease | Q41862798 | ||
| Chemically induced mouse models of intestinal inflammation | Q42510602 | ||
| Damage to the enteric nervous system in experimental colitis | Q42795005 | ||
| Role of human umbilical cord mesenchymal progenitors conditioned media in neuronal/glial cell densities, viability, and proliferation | Q43475143 | ||
| Morphological and functional alterations of the myenteric plexus in rats with TNBS-induced colitis | Q43793241 | ||
| Enhanced excitability of myenteric AH neurones in the inflamed guinea-pig distal colon | Q44300149 | ||
| Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation | Q44317237 | ||
| Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease. | Q44369858 | ||
| Development of myenteric cholinergic neurons in ChAT-Cre;R26R-YFP mice | Q44525479 | ||
| Segmentation induced by intraluminal fatty acid in isolated guinea-pig duodenum and jejunum. | Q44750434 | ||
| Myenteric plexus injury and apoptosis in experimental colitis. | Q45202738 | ||
| High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study | Q45826653 | ||
| Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease | Q45861396 | ||
| Slow synaptic transmission in myenteric AH neurons from the inflamed guinea pig ileum. | Q45952546 | ||
| Structural changes in the epithelium of the small intestine and immune cell infiltration of enteric ganglia following acute mucosal damage and local inflammation. | Q45973882 | ||
| Morphological and functional changes in guinea-pig neurons projecting to the ileal mucosa at early stages after inflammatory damage. | Q46159896 | ||
| Mesenchymal stem cells induce apoptosis of activated T cells | Q46622786 | ||
| Indiscriminate loss of myenteric neurones in the TNBS-inflamed guinea-pig distal colon | Q46632504 | ||
| Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs | Q46838438 | ||
| Human adipose-derived mesenchymal stem cells engineered to secrete IL-10 inhibit APC function and limit CNS autoimmunity. | Q48182778 | ||
| Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study | Q48321211 | ||
| Phenotypic changes of morphologically identified guinea-pig myenteric neurons following intestinal inflammation | Q48585316 | ||
| Mesenchymal stromal cells rescue cortical neurons from apoptotic cell death in an in vitro model of cerebral ischemia | Q48684091 | ||
| P433 | issue | 11 | |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| P304 | page(s) | G1115-29 | |
| P577 | publication date | 2014-10-09 | |
| P1433 | published in | American Journal of Physiology - Gastrointestinal and Liver Physiology | Q15765756 |
| P1476 | title | Mesenchymal stem cells and conditioned medium avert enteric neuropathy and colon dysfunction in guinea pig TNBS-induced colitis | |
| P478 | volume | 307 |
| Q36419634 | Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis. |
| Q48052848 | Alterations of colonic function in the Winnie mouse model of spontaneous chronic colitis. |
| Q26777430 | Animal models to study acute and chronic intestinal inflammation in mammals |
| Q93044698 | Bone marrow-derived CXCR4-overexpressing MSCs display increased homing to intestine and ameliorate colitis-associated tumorigenesis in mice |
| Q90733799 | Cell membrane and bioactive factors derived from mesenchymal stromal cells: Cell-free based therapy for inflammatory bowel diseases |
| Q39200926 | Challenges for epigenetic research in inflammatory bowel diseases |
| Q28081921 | Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease |
| Q37602646 | Effect of mesenchymal stem cells on small intestinal injury in a rat model of acute necrotizing pancreatitis |
| Q36361561 | Human adult stem cells derived from adipose tissue and bone marrow attenuate enteric neuropathy in the guinea-pig model of acute colitis. |
| Q90465459 | Human umbilical cord-derived mesenchymal stem cells ameliorate the enteropathy of food allergies in mice |
| Q38983878 | Mesenchymal Stem Cell Treatment of Inflammation-Induced Cancer |
| Q91670693 | Network-Based Selection of Candidate Markers and Assays to Assess the Impact of Oral Immune Interventions on Gut Functions |
| Q27316366 | Neuroprotective Potential of Mesenchymal Stem Cell-Based Therapy in Acute Stages of TNBS-Induced Colitis in Guinea-Pigs |
| Q35702033 | Potent Paracrine Effects of human induced Pluripotent Stem Cell-derived Mesenchymal Stem Cells Attenuate Doxorubicin-induced Cardiomyopathy |
| Q40779206 | Specific immunotherapy generates CD8(+) CD196(+) T cells to suppress lung cancer growth in mice |
| Q57538743 | The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the Treatment of Immune-Related Diseases: A Systematic Review |
| Q91604604 | The efficacy of conditioned medium released by tonsil-derived mesenchymal stem cells in a chronic murine colitis model |
| Q33577019 | The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis |
| Q41997332 | Therapeutic effects of human amnion-derived mesenchymal stem cell transplantation and conditioned medium enema in rats with trinitrobenzene sulfonic acid-induced colitis |
Search more.